摘要
目的研究分析注射用重组人尿激酶原静脉溶栓成功抢救急性心肌梗死的临床意义。方法抽取2014年7月～2015年7月在我院进行抢救治疗的2例典型的急性心肌梗死患者,均应用注射用重组人尿激酶原溶栓治疗,观察其抢救的效果。结果例1：1周后复查心肌酶恢复正常。12 d后患者到上级医院行冠脉造影示病变轻度狭窄,血运供应尚可。例2：复查心电图示窦性心律、V2～4高耸T波已下降接近正常、偶发室早。4 d后行冠脉造影病变支轻度狭窄,血运供应尚可。结论注射用重组人尿激酶原静脉溶栓治疗急性心梗死,可快速开通闭塞的冠脉,促使心肌得到及时再灌注,以利于成功抢救患者的生命。
Objective Research and analysis recombinant human urokinase for injection successful rescue of clinical significance intravenous thrombolysis in acute myocardial infarction. Methods 2 cases of typical acute myocardial infarction patients were chosen in July 2014 ～ July 2015 in our hospital, thrombolytic therapy were applied recombinant human urokinase for injection observe the rescue effect. Results Example 1： one week after the review of cardiac enzymes returned to normal. 12 days after the patient to a higher level hospital coronary angiography showed lesions showed mild stenosis, revascularization supply acceptable. Example 2： Review electrocardiogram showed sinus rhythm, V2～4 tall T wave has fallen close to normal, occasional room early. 4 days after coronary angiography mild stenosis diseased vessels, blood supply can still supply.Conclusion Recombinant human urokinase for injection intravenous thrombolysis for acute heart infarction, coronary artery occlusion can be quickly opened, prompting timely myocardial reperfusion, in order to facilitate the successful rescue of the lives of patients.
出处
《中国继续医学教育》
2015年第27期168-169,共2页
China Continuing Medical Education
关键词
注射用重组人尿激酶原
静脉溶栓
抢救
急性心肌梗死
Recombinant human urokinase for injection
Thrombolysis
Rescue
Acute myocardial infarction
